Back
Akari Therapeutics Plc Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
AKTX
Akari Therapeutics Plc
Last Price:
$0.27
Seasonality Move:
-23.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akari Therapeutics Plc Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.29 | Sell |
| 20-day SMA: | 0.35 | Sell |
| 50-day SMA: | 0.54 | Sell |
| 200-day SMA: | 0.97 | Sell |
| 8-day EMA: | 0.29 | Sell |
| 20-day EMA: | 0.35 | Sell |
| 50-day EMA: | 0.51 | Sell |
| 200-day EMA: | 0.97 | Sell |
Akari Therapeutics Plc Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 33.62 | Sell |
| Chaikin Money Flow: | 864475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.45) | Sell |
| Bollinger Bands (100): | (0.49 - 0.97) | Sell |
Akari Therapeutics Plc Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics Plc Stock
Is Akari Therapeutics Plc Stock a Buy?
-
Akari Therapeutics Plc share price is 0.27 while AKTX 8-day simple moving average is 0.29, which is a Sell signal.
-
The stock price of AKTX is 0.27 while Akari Therapeutics Plc 20-day SMA is 0.35, which makes it a Sell.
-
Akari Therapeutics Plc 50-day simple moving average is 0.54 while AKTX share price is 0.27, making it a Sell technically.
-
AKTX stock price is 0.27 and Akari Therapeutics Plc 200-day simple moving average is 0.97, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
7
Akari Therapeutics Plc (AKTX)
is a Sell
Is Akari Therapeutics Plc a Buy or a Sell?
-
Akari Therapeutics Plc stock is rated a SellThe current Akari Therapeutics Plc [AKTX] share price is $0.27. The Score for AKTX is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics Plc Stock Info
Market Cap:
9.5M
Price in USD:
0.27
Share Volume:
1.5M
Akari Therapeutics Plc 52-Week Range
52-Week High:
1.73
52-Week Low:
0.22
Sell
7
Akari Therapeutics Plc (AKTX)
is a Sell
Akari Therapeutics Plc Share Price Forecast
-
What is the Akari Therapeutics Plc stock price today?The Akari Therapeutics Plc stock price is 0.27 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics Plc> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics Plc overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics Plc is overvalued.
Is Akari Therapeutics Plc Stock a Buy?
-
Akari Therapeutics Plc share price is 0.27 while AKTX 8-day exponential moving average is 0.29, which is a Sell signal.
-
The stock price of AKTX is 0.27 while Akari Therapeutics Plc 20-day EMA is 0.35, which makes it a Sell.
-
Akari Therapeutics Plc 50-day exponential moving average is 0.51 while AKTX share price is 0.27, making it a Sell technically.
-
AKTX stock price is 0.27 and Akari Therapeutics Plc 200-day simple moving average is 0.97, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics Plc
Is Akari Therapeutics Plc a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.07 per share, and an increase next year of $0.03 per share.
Technical Analysis of Akari Therapeutics Plc
Should I short Akari Therapeutics Plc stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Akari Therapeutics Plc is a Sell
-
Akari Therapeutics Plc Relative Strength Index (RSI) is 33.62, which suggest Akari Therapeutics Plc is oversold
-
The Bollinger Bands (25) for Akari Therapeutics Plc is (0.29 - 0.45), which suggest Akari Therapeutics Plc is a Sell
-
The Bollinger Bands (100) for Akari Therapeutics Plc is (0.49 - 0.97), which suggest Akari Therapeutics Plc is a Sell
* Akari Therapeutics Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.